These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8457385)
21. (2'-5')Oligoadenylate and intracellular immunity against retrovirus infection. Schröder HC; Suhadolnik RJ; Pfleiderer W; Charubala R; Müller WE Int J Biochem; 1992; 24(1):55-63. PubMed ID: 1374726 [TBL] [Abstract][Full Text] [Related]
22. Activation of the 2-5OAS/RNase L pathway in CVB1 or HAV/18f infected FRhK-4 cells does not require induction of OAS1 or OAS2 expression. Kulka M; Calvo MS; Ngo DT; Wales SQ; Goswami BB Virology; 2009 May; 388(1):169-84. PubMed ID: 19383565 [TBL] [Abstract][Full Text] [Related]
23. Cell-mediated infection of human placental trophoblast with HIV in vitro. Douglas GC; Fry GN; Thirkill T; Holmes E; Hakim H; Jennings M; King BF AIDS Res Hum Retroviruses; 1991 Sep; 7(9):735-40. PubMed ID: 1742080 [TBL] [Abstract][Full Text] [Related]
25. 2',5'-Oligoadenylate (2-5A) binding protein (RNase L) changes in AIDS and mammalian cells/tissues. Wu JM; Chang CC; Chiao JW; Wang CH J Exp Pathol; 1990; 5(2):79-88. PubMed ID: 2090799 [No Abstract] [Full Text] [Related]
26. Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A. Silverman RH; Weiss SR J Interferon Cytokine Res; 2014 Jun; 34(6):455-63. PubMed ID: 24905202 [TBL] [Abstract][Full Text] [Related]
27. Comparative studies on (2'-5')oligoadenylate-related enzyme systems and the antiviral effect of interferon in two mouse cell lines which differ in (2'-5')oligoadenylate sensitivity of their protein synthesizing system. Taira H; Yamamoto F; Furusawa M; Sawai H; Kawakita M J Interferon Res; 1985; 5(4):583-96. PubMed ID: 2418128 [TBL] [Abstract][Full Text] [Related]
28. Photolabeling of the enzymes of the 2-5A synthetase/RNase L/p68 kinase antiviral systems with azido probes. Suhadolnik RJ Prog Mol Subcell Biol; 1994; 14():260-75. PubMed ID: 7520331 [No Abstract] [Full Text] [Related]
29. Alteration of nuclear (2'-5')oligoriboadenylate synthetase and nuclease activities preceding replication of human immunodeficiency virus in H9 cells. Schröder HC; Wenger R; Rottmann M; Müller WE Biol Chem Hoppe Seyler; 1988 Sep; 369(9):985-95. PubMed ID: 3228494 [TBL] [Abstract][Full Text] [Related]
31. Mechanism of the antiretroviral effect of dsRNA. Müller WE; Ushijima H; Schröder HC Prog Mol Subcell Biol; 1994; 14():66-88. PubMed ID: 7914807 [No Abstract] [Full Text] [Related]
32. Comparative study of 2',5'-oligoadenylate (2-5A) synthetase in control and Alzheimer's disease (AD) cells. An S; Wu JM Biochem Mol Biol Int; 1994 Apr; 32(6):1003-8. PubMed ID: 8061616 [TBL] [Abstract][Full Text] [Related]
33. Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L. Anderson BR; Muramatsu H; Jha BK; Silverman RH; Weissman D; Karikó K Nucleic Acids Res; 2011 Nov; 39(21):9329-38. PubMed ID: 21813458 [TBL] [Abstract][Full Text] [Related]
34. Interruption of myogenesis by transforming growth factor beta 1 or EGTA inhibits expression and activity of the myogenic-associated (2'-5') oligoadenylate synthetase and PKR. Salzberg S; Mandelboim M; Zalcberg M; Shainberg A Exp Cell Res; 1995 Jul; 219(1):223-32. PubMed ID: 7628537 [TBL] [Abstract][Full Text] [Related]
35. 2'-5'-Oligoadenylate synthetase is activated by a specific RNA sequence motif. Kodym R; Kodym E; Story MD Biochem Biophys Res Commun; 2009 Oct; 388(2):317-22. PubMed ID: 19665006 [TBL] [Abstract][Full Text] [Related]